Singulair (montelukast) for asthma
March 1998
Merck is introducing Singulair (montelukast) for asthma.
It's a new leukotriene antagonist...in the same class as Accolate (zafirlukast). It's a little different than Zyflo.
Singulair and Accolate block the ACTION of leukotrienes in the lungs...Zyflo (zileuton) inhibits their PRODUCTION.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote